| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the City of London Migraine Clinic (E.A.M., A.F.), Departments of Gynaecology and Sexual Health (E.A.M.), St Bartholomew’s Hospital, and Cancer Research UK and University College London Cancer Trials Centre (A.H.), London, and Unipath Limited (J.E.), Priory Park, Bedford, Unilever Research (L.A.), Colworth House, Sharnbrook, UK.
* To whom correspondence should be addressed. E-mail: anne.macgregor{at}bartsandthelondon.nhs.uk.
Abstract-- Objective: To investigate the association between urinary hormone levels and migraine, with particular reference to rising and falling levels of estrogen across the menstrual cycle in women with menstrual and menstrually related migraine. Methods: Women with regular menstrual cycles, who were not using hormonal contraception or treatments and who experienced between one and four migraine attacks per month, one of which regularly occurred on or between days 1 ± 2 of menstruation, were studied for three cycles. Women used a fertility monitor to identify ovulation, conducting a test each day as requested by the monitor, using a sample of early morning urine. Urine samples were collected daily for assay of estrone-3-glucuronide, pregnanediol 3-glucuronide, follicle-stimulating hormone, and luteinizing hormone. All women kept a daily migraine diary and continued their usual treatment for migraine. Results: Of 40 women recruited, data from 38 women were available for analysis. Compared with the expected number of attacks, there was a significantly higher number of migraine attacks during the late luteal/early follicular phase of falling estrogen and lower number of attacks during rising phases of estrogen. Conclusion: These findings confirm a relationship between migraine and changing levels of estrogen, supporting the hypothesis of perimenstrual but not postovulatory estrogen "withdrawal" migraine. In addition, rising levels of estrogen appear to offer some protection against migraine.
This article has been cited by other articles:
|
|
 |
|
  R. E Nappi, G. Sances, S. Detaddei, A. Ornati, L. Chiovato, and F. Polatti Hormonal management of migraine at menopause Menopause Int, June 1, 2009; 15(2): 82 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M. Miller and S. P. Duckles Vascular Actions of Estrogens: Functional Implications Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Pringsheim, W. J. Davenport, and D. Dodick Acute treatment and prevention of menstrually related migraine headache: Evidence-based review Neurology, April 22, 2008; 70(17): 1555 - 1563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lahm, K. M. Patel, P. R. Crisostomo, T. A. Markel, M. Wang, C. Herring, and D. R. Meldrum Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycle Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E865 - E871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Menstrual Migraine: The Estrogen Paradox Journal Watch Neurology, March 13, 2007; 2007(313): 2 - 2. [Full Text]
|
|
|
|
|
|
E. A. MacGregor, A. Frith, J. Ellis, L. Aspinall, and A. Hackshaw Prevention of menstrual attacks of migraine: A double-blind placebo-controlled crossover study Neurology, December 26, 2006; 67(12): 2159 - 2163. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
